Regenerating the Anal Sphincter: Cytokines, Stem Cells, or Both?

Area of Science:

• Regenerative Medicine
• Gastroenterology
• Biomaterials Science

Background:

• Anal sphincter defects pose a significant challenge for healing, especially when occurring long after the initial injury.
• Current therapeutic strategies for sphincter defects often yield suboptimal functional outcomes.

Purpose of the Study:

• To investigate the efficacy of re-establishing stem cell homing via stromal-derived factor 1 (SDF-1) plasmid delivery in promoting anal sphincter regeneration.
• To evaluate the combined effect of SDF-1 plasmid and mesenchymal stem cells (MSCs) on functional and anatomical outcomes of sphincter defects.

Main Methods:

• A randomized animal study involving 32 female Sprague Dawley rats with 50% anal sphincter complex excision.
• Four intervention groups were established 3 weeks post-injury: no intervention, SDF-1 plasmid only, SDF-1 plasmid with MSCs, and SDF-1 plasmid with MSCs in a gelatin scaffold.
• Functional analysis was based on anal sphincter resting pressures, and histological analysis used Masson staining.

Main Results:

• All three intervention groups demonstrated significantly improved resting pressures compared to the control group.
• The SDF-1 plasmid with MSCs group exhibited enhanced muscle architecture organization and increased muscle percentage.
• Histological analysis revealed significantly more muscle and less fibrosis at the defect site in the plasmid and plasmid-plus-cells groups compared to controls.

Conclusions:

• Local delivery of SDF-1 plasmid, with or without MSCs, promotes anal sphincter muscle regeneration and improves functional outcomes.
• This approach offers a promising strategy for treating chronic anal sphincter defects.
• Further evaluation of midterm outcomes and detailed muscle morphology is warranted.